Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
about
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)Fluoroquinolones for treating tuberculosisEffects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-AnalysisQuality of outcome reporting in phase II studies in pulmonary tuberculosisCurrent prospects for the fluoroquinolones as first-line tuberculosis therapyAntituberculosis therapy for 2012 and beyondGender analysis of moxifloxacin clinical trialsThe Effectiveness and Safety of Fluoroquinolone-Containing Regimen as a First-Line Treatment for Drug-Sensitive Pulmonary Tuberculosis: A Systematic Review and Meta-AnalysisMoxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialDocking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.Investigational antimicrobial agents of 2013.Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisRetrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.New regimens for reducing the duration of the treatment of drug-susceptible pulmonary tuberculosis.Current development and future prospects in chemotherapy of tuberculosisCorrelation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamideDrug-resistant tuberculosis: controversies and challenges in pediatrics.Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.Powerful bactericidal activity of moxifloxacin in human leprosy.Accumulating Evidence and Research Organization (AERO) model: a new tool for representing, analyzing, and planning a translational research program.Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.Evolution of central nervous system multidrug-resistant Mycobacterium tuberculosis and late relapse of cryptic prosthetic hip joint tuberculosis: complications during treatment of disseminated isoniazid-resistant tuberculosis in an immunocompromisedChemotherapeutic interventions against tuberculosisNew drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.Extensively drug-resistant tuberculosis: new strains, new challenges.Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: Part II: scientific advances that may provide solutionsRecent advances in antituberculous drug development and novel drug targets.The early bactericidal activity of antituberculosis drugs.Nanocarrier-based interventions for the management of MDR/XDR-TB.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Development of new antituberculous agents based on new drug targets and structure-activity relationship.Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Assessment of the Efficacy of New Anti-Tuberculosis Drugs.Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.
P2860
Q24202081-B8B48BCE-6BC9-4DBC-9FBF-AD0559C4C650Q24242773-C14EC542-126A-4740-9AC0-B318DA03F652Q26775757-4A43158C-80B6-43FA-BCDD-ABCB76857434Q26777160-7CE23A3E-6341-458F-B097-D7FCE2C9E352Q26823843-549270E1-BA35-49E6-8B5C-38CFAEB0FF76Q26829101-A8D21172-ECF1-4044-9216-808354D51A35Q28538319-0D1F6C13-DE9E-4266-A883-20D793CF13DDQ28553119-6C5DB775-3D2B-4925-AE2A-3B18C92EC5DCQ33837706-75031104-DBF1-433C-95AC-95BA104869E5Q34094873-27180C6D-DE4B-48C4-ACE0-9D5003C72089Q34340538-137F6E26-480E-4ED9-B4E5-798346DBDB53Q34375204-B481DD61-3D7E-4101-8104-AEBE16162E53Q34777926-6660E7A5-7FC1-4D56-986A-CD4066FF0548Q35033562-6481BFA7-07E7-407E-889D-D5FCDFF0DCAFQ35676180-5087E6D7-3D98-48EC-83F1-3CEDF7BC53D2Q35705874-2553AB26-B801-445F-A889-6819A7A71D44Q35960685-167F9E46-69FF-48BE-8FB4-E36CA1ADCF3DQ36236341-2881B78F-73F7-41E3-B696-AA71584B1D64Q36322140-25C5BDCE-4069-45C1-AA5A-5DED4AAB2981Q36650622-35743265-0C37-49B7-BABF-1A2CEC6A1688Q36870814-A3B6D80B-96E8-425C-B8D0-92993FF65E92Q36905756-E0A8DE77-534E-4699-A1D5-71240D834323Q36928273-EE8CFA84-D77E-4636-B758-3745FAB38A0FQ37074826-FBE0E0DB-ABEB-4078-A163-0D485190C985Q37099576-17A6DB0F-8CD6-4415-BBFB-C0E614A0CB72Q37148764-9528D23C-9F4B-4C89-A197-F60B670ADF13Q37150326-83970C68-80D3-446A-972C-3FBB380BA8BBQ37291363-4AEB0ECF-6EBD-4098-B7C7-AC6E8414DE5BQ37339276-8754807B-54AA-42B1-AEE2-FBD2BBA8E541Q37346929-B6F2EF0E-E0CC-4914-A52C-7BDBBE8660F4Q37742687-5BED359B-3F08-44E7-97B6-F5150CAA6566Q37754884-343BD7DA-4797-4C7F-B2E6-7F120392F727Q38176039-72614766-36DE-4CA6-8B93-4BB35482DEC8Q38375982-C4FBF70E-6CEA-4ECB-A034-AE2D524C3A3CQ39456569-58F64B5B-8B71-41BA-9BD5-5FCCCA60246BQ39967041-2475BF4C-DFCF-4446-AA98-1E986677DB57Q40138610-B77059A4-3A4B-4C6D-9F34-F5879B34C1EFQ40363572-58E90488-C173-47B4-8FB2-42ECE08A5CB3Q41572870-04493A8A-47D2-4132-B8D6-914D8B7EBE6CQ41876123-FBCFAC48-AE64-463D-B547-F63AB0D200FA
P2860
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Early bactericidal activity of ...... prospective, randomized study.
@ast
Early bactericidal activity of ...... prospective, randomized study.
@en
type
label
Early bactericidal activity of ...... prospective, randomized study.
@ast
Early bactericidal activity of ...... prospective, randomized study.
@en
prefLabel
Early bactericidal activity of ...... prospective, randomized study.
@ast
Early bactericidal activity of ...... prospective, randomized study.
@en
P2093
P2860
P1476
Early bactericidal activity of ...... prospective, randomized study
@en
P2093
Andreas Roth
Andres De Roux
Harald Mauch
Hartmut Lode
Karl-Heinz Neumann
P2860
P304
P356
10.1128/AAC.48.3.780-782.2004
P407
P577
2004-03-01T00:00:00Z